Connexin 32 downregulation is critical for chemoresistance in oxaliplatin-resistant HCC cells associated with EMT

Background: Oxaliplatin (OXA)-based chemotherapy is critical in the management of advanced hepatocellular carcinoma (HCC); however, acquired drug resistance has largely restricted its clinical efficacy. This study aims to explore the key mechanisms and regulatory factors determining chemosensitivity...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Manag Res
Egile Nagusiak: Yang, Yan, Yao, Jing-Hao, Du, Qian-Yu, Zhou, Yong-Chun, Yao, Ting-Jing, Wu, Qiong, Liu, Jing, Ou, Yu-Rong
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove 2019
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6549660/
https://ncbi.nlm.nih.gov/pubmed/31213923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S203656
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak